Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 78,837,943
- Total 13F shares
- 54,112,686
- Share change
- +1,351,847
- Total reported value
- $503,299,407
- Put/Call ratio
- 28%
- Price per share
- $9.13
- Number of holders
- 115
- Value change
- +$11,390,968
- Number of buys
- 66
- Number of sells
- 38
Report period
Q4 2023
Institutions
115
Top holders
10
PHAT full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
13%
|
10,109,279
|
$104,833,223 | — | 30 Sep 2023 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
|
Company |
4.8%
|
3,760,869
|
$39,000,212 | — | 30 Sep 2023 | |
| Carlyle Group Inc. |
13F
|
Company |
4.4%
|
3,496,808
|
$36,191,963 | — | 30 Sep 2023 | |
| Invesco Ltd. |
13F
|
Company |
4.3%
|
3,418,959
|
$35,454,604 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
2,437,742
|
$25,279,384 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
1,922,662
|
$19,938,004 | — | 30 Sep 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.2%
|
1,732,172
|
$17,962,623 | — | 30 Sep 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
2.1%
|
1,617,300
|
$16,771,401 | — | 30 Sep 2023 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.7%
|
1,310,048
|
$13,585,198 | — | 30 Sep 2023 | |
| NEA Management Company, LLC |
13F
|
Company |
1.6%
|
1,276,595
|
$12,238,290 | — | 30 Sep 2023 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.4%
|
1,100,000
|
$11,407,000 | — | 30 Sep 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,061,745
|
$11,010,296 | — | 30 Sep 2023 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
1.1%
|
850,000
|
$8,814,500 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.94%
|
740,021
|
$7,674,018 | — | 30 Sep 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.89%
|
700,000
|
$7,259,000 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
682,570
|
$7,079,127 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.85%
|
667,596
|
$6,922,971 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.73%
|
577,450
|
$5,988,000 | — | 30 Sep 2023 | |
| Newtyn Management, LLC |
13F
|
Company |
0.63%
|
500,000
|
$5,185,000 | — | 30 Sep 2023 | |
| StepStone Group LP |
13F
|
Company |
0.54%
|
422,085
|
$4,377,021 | — | 30 Sep 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.5%
|
395,000
|
$4,096,150 | — | 30 Sep 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
0.44%
|
347,332
|
$3,601,833 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
287,834
|
$2,984,839 | — | 30 Sep 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.36%
|
280,932
|
$2,913,265 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.35%
|
275,727
|
$2,859,289 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
268,776
|
$2,787,207 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
246,681
|
$2,558,082 | — | 30 Sep 2023 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.3%
|
237,935
|
$2,467,386 | — | 30 Sep 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.28%
|
220,000
|
$2,281,400 | — | 30 Sep 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.2%
|
160,000
|
$1,659,200 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.18%
|
144,756
|
$1,501,119 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
139,348
|
$1,445,039 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
138,500
|
$1,436,245 | — | 30 Sep 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.17%
|
130,564
|
$1,353,949 | — | 30 Sep 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.15%
|
121,892
|
$1,264,000 | — | 30 Sep 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.15%
|
117,280
|
$1,216,194 | — | 30 Sep 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.13%
|
99,810
|
$1,035,030 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
95,065
|
$985,824 | — | 30 Sep 2023 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.12%
|
91,820
|
$952,000 | — | 30 Sep 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.11%
|
85,372
|
$885,308 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
84,063
|
$871,733 | — | 30 Sep 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
83,756
|
$868,550 | — | 30 Sep 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.1%
|
82,148
|
$851,875 | — | 30 Sep 2023 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.1%
|
80,000
|
$829,600 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
78,244
|
$811,391 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
70,784
|
$734,031 | — | 30 Sep 2023 | |
| Penn Mutual Asset Management |
13F
|
Company |
0.08%
|
62,802
|
$651,257 | — | 30 Sep 2023 | |
| Swiss National Bank |
13F
|
Company |
0.08%
|
60,200
|
$624,274 | — | 30 Sep 2023 | |
| Trexquant Investment LP |
13F
|
Company |
0.07%
|
58,825
|
$610,015 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
56,537
|
$586,276 | — | 30 Sep 2023 |
Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q4 2023
As of 31 Dec 2023,
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,112,686 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., TAKEDA PHARMACEUTICAL CO LTD, Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., Invesco Ltd., BlackRock Inc., Ensign Peak Advisors, Inc, NEA Management Company, LLC, VANGUARD GROUP INC, and Avidity Partners Management LP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
109
Q4 2023 holders
115
Holder diff
6
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.